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Abstract
Alpha-fetoprotein (AFP)-producing primary lung tumours are rare; 
we present the first case of an AFP-producing lung tumour with 
metastasis to testes. The patient, a 72-year-old man, presented 
with a history of flu-like symptoms and abdominal pain. On exami-
nation he had a hard, tender left scrotal mass. Imaging showed a 
4.4-cm right lower lobe lung mass and the serum-AFP was raised 
(1189 ng/mL). Left orchidectomy excised a necrotic tumour. 
Microscopy showed complete hemorrhagic infarction and immu-
nohistochemistry showed a lack of staining for AFP. Serum-AFP 
rose 3 days post-orchidectomy to 1466 ng/mL. The patient sub-
sequently developed melaena and died. Autopsy revealed a 9 × 
5-cm necrotic right lower lobe lung tumour. Immunohistochemistry 
showed the tumour cells reacted with a pan-cytokeratin antibody 
and less than 5% expressed AFP. Bilateral adrenal tumour deposits 
were also identified in addition to those in the bowel and spleen. 
The expression of AFP solely in the lung lesion and lack of expres-
sion in both testes, together with a rise in serum-AFP post-orchid-
ectomy and the bilateral adrenal metastases, is overwhelming evi-
dence for the reversal of the usual situation: a poorly differentiated 
AFP-secreting metastatic lung adenocarcinoma.
Introduction 
Alpha-fetoprotein (AFP) is an important diagnostic tumour 
marker for hepatocellular carcinoma (HCC) and germ cell 
tumours (GCT).1 AFP-producing primary lung tumours are 
rare; therefore, an elevated serum-AFP in conjunction with 
a lung neoplasm is most likely to represent a metastasis. We 
present a case of an AFP-secreting metastatic lung neoplasm.
Case report 
A 72-year-old man presented with flu-like symptoms and 
abdominal pain. His medical history included hypercholes-
terolaemia, hypertension, chronic obstructive airways dis-
ease and alcohol excess. His drug history included lisinopril, 
simvastatin and amitryptiline. He had a 60-pack/year smok-
ing history and was a retired coal miner.
On examination, he was hypotensive (100/50 mmHg) and 
tachycardic (pulse 120 bpm). His abdomen was soft, but ten-
der in the suprapubic region; the bowel sounds were normal. 
He had a hard, tender left scrotal mass. Initial investigations 
revealed acute renal failure (urea 17.2 mmol/L; creatinine 
327 mmol/L) and a macrocytic anemia (Hb 91 g/L; MCV 
107 fL).
A computed tomography angiogram revealed a suspi-
cious mass at the right lung base. Further imaging showed 
a 4.4-cm right lower lobe lung mass and a 3-cm mass con-
tiguous with extensive right hilar lymph node enlargement. 
Bilateral enlarged adrenal glands, with cortical enhance-
ment, and a thickened segment of small bowel, not seen on 
the initial scan, were also identified. Testicular ultrasound 
scan showed a 6 × 4 × 5-cm heterogeneous left scrotal 
mass. In an assessment of serum tumour markers, AFP was 
raised at 1189 ng/mL (lactate dehydrogenase and b-human 
chorionic gonadotrophin [b-hCG] were normal).
A provisional diagnosis of an AFP-secreting testicular 
neoplasm with pulmonary metastases was made. Although 
unusual in a 72-year-old, this diagnosis offered the possibil-
ity of a cure.
Left orchidectomy excised a 4 × 4 × 7-cm hemorrhagic and 
necrotic tumour. Microscopy showed complete hemorrhagic 
infarction with peripheral fibrosis and attendant inflamma-
tion. The tumour had not breached the tunica albuginea or 
involved the rete testes or epididymis. Vacuolated cells were 
identified within the seminiferous tubules raising the possibil-
ity of co-existing intra-tubular germ cell neoplasia-unspeci-
fied. These features were consistent with a primary testicular 
tumour, which had undergone hemorrhagic infarction.
The patient subsequently started a course of carbopla-
tin and etoposide chemotherapy. However, 3 days later he 
developed melena. Attempts at resuscitation were unsuc-
cessful and he died.
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An autopsy showed a 9 × 5-cm necrotic right lower 
lobe lung tumour. Microscopy showed a poorly cohesive, 
extensively necrotic, pleomorphic neoplasm (Fig. 1a). The 
tumour cells had a high nucleus-to-cytoplasmic ratio, coarse 
chromatin and, in a high percentage of cells, a single eosi-
nophilic nucleolus; mitotic figures were readily identified. 
Tumour replaced and extended beyond a lymph node at 
the main bronchus.
Immunohistochemical analyses of the lung lesion showed 
the tumour cells reacted with a pan-cytokeratin (CK) anti-
body and less than 5% expressed AFP (Fig. 1b). There was 
no evidence of CK7, thyroid-transcription factor-1, CEA, syn-
aptophysin, OCT 3/4, CD30, b-hCG or CD117 expression. 
This profile is not typical of an embryonal carcinoma or a 
primary lung tumour, but could be consistent with a GCT 
with yolk sac-like features.
A tumour nodule within the jejunal mesentery had eroded 
into the bowel lumen, and was associated with distal gastro-
intestinal hemorrhage (the cause of the melena). Microscopy 
showed a glandular neoplasm with a similar immunopro-
file to the lung tumour. Both adrenals were replaced by 
adenocarcinoma and the tumour was also present in the 
spleen. There was no evidence of tumour in the stomach 
or pancreas.
The original left orchidectomy specimen was examined 
further. Immunocytochemistry did not detect placental alka-
line phosphatase or OCT 3/4 expression, indicating that the 
vacuolated cells within the seminiferous tubules were likely 
due to tubular atrophy. Immunohistochemical analyses of the 
right testes showed simple atrophy. Importantly, neither the 
left or right testicle expressed AFP. This suggests the testicular 
lesion was almost certainly a necrotic metastasis, substanti-
ated by a rise in the serum-AFP level to 1466 ng/mL 3 days 
post-orchidectomy. The most likely diagnosis is that of a 
poorly differentiated AFP-secreting metastatic lung adeno-
carcinoma.
Discussion 
AFP is an oncofetal antigen with an important diagnostic 
role in primary liver tumours and GCTs.1-3 There is evidence 
gastric and pancreatic carcinomas may also produce AFP.4,5 
Reports of primary AFP-secreting lung tumours are rare.6-8
Lung metastases from a primary liver tumour or GCT can 
produce AFP. AFP levels can be elevated in patients with 
primary lung carcinoma associated with liver metastases; it 
is believed that regenerating hepatocytes surrounding the 
metastatic tumour cells are the source of AFP.9-10 Reports of 
AFP-producing primary lung cancer in the absence of liver 
metastases also exist.6-8 To our knowledge, this is the only 
reported case of an AFP-producing lung cancer, without liver 
involvement, associated with testicular metastasis.
The transcriptional and epigenetic changes responsible 
for the rare expression of AFP in primary lung neoplasms are 
unclear; it has been proposed that cell context may facili-
tate this process. One theory invokes the shared embryo-
logical origin of the lung, liver, pancreas and stomach and 
suggests that a common ontological heritage may partly 
explain “inappropriate” AFP-expression by tumours arising 
from these sites.1
In this case, the serum-AFP level was persistently elevated 
after orchidectomy, possibly caused by metastatic disease. It 
highlights that tumour markers can be difficult to interpret; 
the normal range does not have a normal distribution and the 
“normal” level for some patients (without an obvious under-
lying cause) is beyond the laboratory range. Furthermore, 
certain conditions and drugs can increase serum-AFP levels, 
specifically alkylating agents. This emphasizes that tumour 
alpha-fetoprotein-producing lung cancer with testicular metastasis
Fig. 1a. Representative photomicrograph of pleomorphic tumour in the right 
lung (haematoxylin and eosin; magnification ×400).
Fig. 1b. Immunohistochemical analysis of alpha-fetoprotein expression by the 
tumour cells (magnification ×400).
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markers are not perfect indicators and must be interpreted 
within the clinical setting and context of multiple investiga-
tive parameters.
This case was reviewed by a specialist uro-pathologist; in 
conjunction with the multidisciplinary team, it was felt that 
the findings of the original left orchidectomy were sufficient 
to support the diagnosis of a metastatic AFP-secreting tumour 
with testicular origin. The fatal gastro-intestinal hemorrhage 
was most likely precipitated by chemotherapy resulting in 
rapid necrosis of the jejunal metastasis. Spontaneous rupture 
of metastases resulting in major hemorrhage can occur prior 
to chemotherapy, although this is rare.11 This case report 
highlights the importance of having a definitive pathological 
diagnosis prior to the initiation of chemotherapy.
Conclusion 
This case report illustrates a reversal from the usual situation. 
Initially it was assumed that the lung lesion was metastatic 
from an AFP-secreting testicular tumour. Although there will 
always be a small degree of conjecture, the expression of 
AFP solely in the lung lesion and lack of expression in both 
testes, together with the rise in serum-AFP post orchidectomy 
and the bilateral adrenal metastases, which are typical for 
lung tumours, make the unusual situation of a primary AFP-
secreting lung lesion with testicular metastases the mostly 
likely diagnosis. Thus, a primary lung neoplasm should be 
considered when a lesion is present within the lung fields 
and the serum-AFP is elevated.
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